Concepedia

Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer

Andrew R. Green, Daniele Soria, Des G. Powe, Chris Nolan, Mohammed A. Aleskandarany, Marcell A. Szász, Anna‐Mária Tõkés, Graham Ball, Jonathan M. Garibaldi, Emad A. Rakha,

Breast Cancer Research and Treatment · 2016 · 31 citations · 29 references

DOIFull text

Open access

Concepts

References

29

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Thérese Sørlie, Charles M. Perou, Robert Tibshirani et al. · Proceedings of the National Academy of Sciences · 2001 · 10.9K citations · Full text

, , +16

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

Marc J. van de Vijver, Yudong D. He, Laura van ‘t Veer et al. · New England Journal of Medicine · 2002 · 6.5K citations · Full text

, , +17

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Soonmyung Paik, Steven Shak, Gong Tang et al. · New England Journal of Medicine · 2004 · 6.4K citations · Full text

, , +12

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

Joel S. Parker, Michael E. Mullins, Maggie C.U. Cheang et al. · Journal of Clinical Oncology · 2009 · 4.9K citations · Full text

, , +16

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz et al. · Journal of Clinical Oncology · 2006 · 4.5K citations · Full text

, , +11